notwithstanding the fact that his rating scale explicitly implies (barring exceptional circumstances) an ability to discern a particular dose to be "not a placebo" (i.e. a +1 or higher).
Shulgin never wrote 10 µg was a + experience, nor did he claim that 60 µg was a +++ experience.
No. Did I say that? Why have you implied that?
I
inferred it because
you implied it when you stated that you take 1/6 of a Shulgin dose for most things.
For many people, 60 ug is enough for a +3.
Oh I see where you're mistaken now. This next part is what I think you have wrong:
In TIHKAL for example, the dose range specified for LSD is 60-200 ug because this is the range of doses within which people typically have +3 experiences.
No, I'm not sure how you extrapolated that Shulgin was describing only the range for a +++ experience. Why would he be so specific for just that range? The range, as he states goes from + to +++ with a ++++ experience reserved for rare instances of a +++ experiences breaking through to a higher level due to various factors and timing that cannot be reliably reproduced on demand. Get some other opinions if you don't believe me.
10 ug is likely enough for most people to experience very mild LSD-like effects including sensory and emotional enhancement, altered cognition, body sensations, stimulation, and maybe some enhancement of background hypnogogic imagery.
Well according to a study from 2021 and another in 2023, very mild cognitive and mood enhancement from microdosing appear to be the result of placebo and the phenomenon of "unblinding" during research. Btw, good word with "hypnogogic".
How the hell would you know?
Uh oh, gettin' spicy now … I know because I'm applying logic, reason, and my own nearly 30 yrs of extensive psychedelic experience.
Do I need to twitch my head for you to believe me?
No, just logic, reason, and studies published in respected journals of science and/or medicine. Nice reference to the head twitch test though!
Seriously. I am intimately familiar with the effects of psychedelics at a wide variety of doses and intensities and have no problem distinguishing between a -, a +/- (ambiguous), and a +1 level experience.
No one said that you didn't. But detection of some mild effects is not what's being tested for; they're testing for measurable cognitive enhancement and self-reported subjective mood boost, something that microdosing so far does not appear to establish as distinguishable from placebo. You need to bear in mind how placebo can cause +1 states, and that passing out after imbibing sugar in orange juice from the placebo effect brought on by thinking that sugar was a sedative… this is what made Shulgin interested in mind-altering drugs. I know you said you know about that, but it's both a reminder and an interesting trivia fact about Shulgin for anyone else reading this.
Sub-hallucinogenic? What a garbage term
Yes, I agree. I didn't come up with the term hallucinogen and I've never liked it not considered it accurate. Regardless, I
still think it's a better definition if forced to choose. My take on it is that microdosing is a placebo.
I'm glad you asked. In the entry for 5-Meo-MiPT where it says: "Dosage: 4 - 6mg, orally; 12-20 mg, smoked", I would consider 4 mg to be the minimum of the published dosage range. For many people (it's subjective on Shulgin's part), 4 mg is just barely enough for a +3.
No, 4 mg is not enough for anyone to have a +++ experience. I know, I've done the drug and seen probably a dozen or more people use it at varying doses. One can get to a + state on 4 mg. However, no one is tripping on 700 µg of Moxy. Talk to anyone who has experience with weighing out and taking Moxy and I promise you they will agree with me.
So 1/6th of that would be ~700 ug.
Yeah the math is right, but your expectation there is the result of your misinterpretation of Shulgin's effects scale.
Unfortunately I have not tried 5-Meo-MiPT, so I don't know how I respond to it.
Yes, it is unfortunate you made that your example without having experience with it while I indeed have had quite a bit of experience and can attest that 0.7 mg of Moxy ain't doing much if anything.
I do tend to be very sensitive to full doses of some tryptamines
So whyTF are you jumping down my throat for suspecting that you're sensitive to serotonergic drugs? You just admitted here that
you think you are sensitive.
like mushrooms, 4-XX-MiPT, and 5-Meo-DMT, the latter of which gives me nasty physical symptoms.
Yeah 5-MeO-DMT nauseates me every single time, and I don't care for it because of this. But it's not just you and I, this is a common response to 5-MeO-DMT. It also doesn't mean someone is sensitive to it, either. You know, every once in a while you might encounter someone with more knowledge on a topic. This might be one of those times for you. And that's neither a flex, nor me being argumentative.
Honestly, I don't think you're a sensitive user. I think you just need to recalibrate your internal Shulgin scale upon gaining the correct calibration. You don't need to get so upset for me disagreeing with you and pointing out the mistakes. I'm not straw-manning your argument, either. I've been quoting you directly and paraphrasing Shulgin. I'm not ascribing some easily attacked argument you didn't make, either. You yourself claimed that 60 µg of LSD is a +++ experience for "most people".
There is tremendous incentive to over-represent the contained dose
LSD trafficking is a bit different, naive though this might initially sound. I also saw that article about 90s doses, but I don't recall the extent to which they considered product degradation to factor into these findings. From what I've seen, LSD is often kept in less-than-ideal storage conditions. Conversely, Owsley would pump out 250 µg tablets in the mid-to-late 60s. So if your point is that it's impossible to know your dose, wouldn't it thus be impossible to microdose with any accuracy. You have to be wrong about one of those two things.
I want to point out also that you're quoting a paper from 2011, and I'm quoting papers from 2021 and 2023. I'm also open to the idea that I'm wrong, but I have yet to see data indicating otherwise. The latest research indicates placebo.
While you say there's tremendous incentive to over-represent, I think there is an equal incentive to produce stronger doses that will outperform weaker doses in the market. Some might disagree, but I think that reputation matters in the drug dealing "game" as it were.
LSD's propensity to decompose under certain conditions and the problems that can arise when blotters are laid or tablets are pressed. Gel tabs can at least be poured from a homogenous solution.
How do you think liquid LSD is produced? From a heterogenous solution? No. And what do you think blotter paper is laid with other than a homogenous mixture? And before you argue about uneven dispersion of LSD on blotter, you should realize that the capillary action within the fibers of blotter paper actually help to reduce this effect. Not saying it doesn't happen, but you should also consider how gel solutions generally require some level of heat, which we know causes some LSD degradation. Also, gel can be relatively thick or thin in areas of a sheet of gel tabs, and those sheets usually have a wide trim border running around the sheet of gel tabs. Is this measured and accounted for? I doubt it. There's always a margin of error. The pharmaceutical industry also has allowable margins of error for their products. Yes, oversight would obviously help, but without it we're also not just cast into the dark ages, you know… Hell, I could buy a used GC-MS machine on eBay if I really wanted to go hard in the paint.
I don't even know what you're saying here.
Yes, that's very obvious. In this instance I was referring to the testing done by a group who called themselves the DNM Avengers (for dark net market avengers), and they tested drugs including various blotter acid purchased from dark net markets. They published both the claimed amount and the amount they tested as active and present on the sample. Despite knowing a lot, are you willing to admit yet that you might have accidentally calibrated your Shulgin scale incorrectly and could possibly just be wrong about this? There's no shame in admitting the mistake. Insistence on being right here is not helping you though.
Considering I posted a study showing that subjects can reliably identify activity from a 13 ug dose in a double-blind test,
Once again, reliably identifying activity is not the same as performing markedly better on a cognitive test with only variable test subjects demonstrating this boost and control test subjects showing no boost. This isn't what happened though. Now consider your study is dated 2011 and the two studies I'm referring to are from 2021 and 2023. Do you think our knowledge and understanding on this subject has regressed over the past 12 years? I can't imagine you would actually claim this.
I don't know why you are fighting this so hard.
Creepy wording. Regardless, this isn't hard, nor is this a fight. Hardly a disagreement if I can get you to see the mistake you made at the core of it all. You simply made a reading comprehension mistake regarding Shulgin's experience scale for a drug (or maybe I did, but I doubt it), and now misapplying it has led to inaccurate conclusions for you. And there's perhaps a bit of Dunning-Kruger effect going on, as well.
Read back over the section in PIHKAL where Shulgin describes those experiences, and pay attention to what he describes as titrating up to the proper dose. He's not calling this range +1. Setting aside Shulgin's scale for a moment, 60 µg is a very light dose, what should be a very mild trip for most folks. Shulgin even says at some point in PIHKAL, recalling a story, how he and Anne took 100 mics to enhance sex which was just enough for light visuals and erotic enhancement without being heavy and distracting. Meanwhile 10 µg - 25 mg might well have discernible effects for most folks, but the reason most people microdose is cognitive enhancement and mood boost. For this former purpose it appears that it is indistinguishable from placebo and therefore not a candidate for this to be developed into a medicine used at that dose range for this purpose.
I think once you calibrate your scale and deepen your understanding of this subject a bit, you'll agree with me. FWIW, you do have an impressive depth of knowledge on the topic compared to most, and you have a decent understanding of many adjunct concepts. I hope I've shown you a few ways in which your argument collapses, and that I also understand how this happened and why it's not a big deal, just something to fix for future convos and debates you might find yourself in IRL. I'm only trying to help my fellow drug enthusiasts become better informed. Much love.